Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr David Hodgson

Res. Fellow in Infectious Dis. Modelling

United Kingdom

Jump to: Affiliations Publications

Affiliations
Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Selected Publications
Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study.
Krauer, F; Guenther, F; Treskova-Schwarzbach, M; Schoenfeld, V; Koltai, M; Jit, M; HODGSON, D; Schneider, U; Wichmann, O; Harder, T; Sandmann, FG; FLASCHE, S;
2024
BMC medicine
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohort.
Sullivan, S; Khvorov, A; Carolan, L; Dowson, L; Hadiprodjo, J; Sánchez-Ovando, S; Liu, Y; Leung, V; HODGSON, D; Blyth, C; Macnish, M; Cheng, A; Hagenauer, M; Clark, J; Dougherty, S; Macartney, K; Koirala, A; Khatami, A; Jadhav, A; Marshall, H; Riley, K; Wark, P; Delahunty, C; Subbarao, K; Kucharski, A; ... Fox, A.
2024
Res Sq
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].
HODGSON, D; Wilkins, N; VAN LEEUWEN, E; Watson, CH; Crofts, J; FLASCHE, S; Jit, M; ATKINS, KE;
2024
The Lancet regional health. Europe
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.
RUSSELL, TW; Townsley, H; Hellewell, J; Gahir, J; Shawe-Taylor, M; Greenwood, D; HODGSON, D; Hobbs, A; Dowgier, G; Penn, R; SANDERSON, T; Stevenson-Leggett, P; Bazire, J; Harvey, R; Fowler, AS; Miah, M; Smith, C; Miranda, M; Bawumia, P; Mears, HV; Adams, L; Hatipoglu, E; O'Reilly, N; Warchal, S; Ambrose, K; ... KUCHARSKI, AJ.
2024
The Lancet. Infectious diseases
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia.
Jarju, S; Wenlock, RD; Danso, M; JOBE, D; Jagne, YJ; Darboe, A; Kumado, M; Jallow, Y; Touray, M; Ceesay, EA; Gaye, H; Gaye, B; Tunkara, A; Kandeh, S; Gomes, M; Sylva, EL; Toure, F; Hornsby, H; Lindsey, BB; Nicklin, MJ; Sayers, JR; SESAY, AK; KUCHARSKI, A; HODGSON, D; KAMPMANN, B; ... De Silva, TI.
2024
Nature communications
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity.
HODGSON, D; Sánchez-Ovando, S; Carolan, L; Liu, Y; Hadiprodjo, AJ; Fox, A; Sullivan, SG; KUCHARSKI, AJ;
2024
medRxiv
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
RUSSELL, TW; Townsley, H; ABBOTT, S; Hellewell, J; Carr, EJ; Chapman, LA C; Pung, R; QUILTY, BJ; HODGSON, D; Fowler, AS; Adams, L; Bailey, C; Mears, HV; Harvey, R; Clayton, B; O'Reilly, N; Ngai, Y; Nicod, J; Gamblin, S; Williams, B; Gandhi, S; Swanton, C; Beale, R; Bauer, DL V; Wall, EC; ... KUCHARSKI, AJ.
2024
PLoS biology
dchodge/rsvmabmat
HODGSON, D;
2024
GitHub
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination.
HODGSON, D; Wilkins, N; VAN LEEUWEN, E; Watson, CH; Crofts, J; FLASCHE, S; JIT, M; ATKINS, KE;
2024
The Lancet Regional Health Europe
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines.
Liu, Y; Sánchez-Ovando, S; Carolan, L; Dowson, L; Khvorov, A; Jessica Hadiprodjo, A; Tseng, YY; Delahunty, C; Khatami, A; Macnish, M; Dougherty, S; Hagenauer, M; Riley, KE; Jadhav, A; Harvey, J; Kaiser, M; Mathew, S; HODGSON, D; Leung, V; Subbarao, K; Cheng, AC; Macartney, K; Koirala, A; Marshall, H; Clark, J; ... Fox, A.
2023
Vaccine
See more information

Contact

United Kingdom